KNW knowlabs.co: Forward P/S Multiple

Graphic logo of Know Labs Corp (KNW)

Know Labs, Inc. (KNW) management aims to verify sensor accuracy and protect patents for certification. The expected P/S dynamics on GURU.Markets reflect price stability, where 5978.50 expresses the metric's value today. A fabless production model with US assembly guarantees quality, yet betting on a single product creates binary risks and dependence on FDA approval.

knowlabs.co - KNW Market Cap to Expected Sales Ratio (period 04/28/2023 - 05/20/2023)

Metric breakdowns and analytics for Know Labs Corporation (KNW)

- current price and projected stock value:
Summary company analytics:Know Labs (KNW)
Product sample of Know Labs, Inc.

Forward P/S evaluates market capitalization relative to projected sales, allowing for the determination of an asset's overvaluation during periods of stagnant demand. By analyzing the expected P/S ratio, investors assess the rate of multiple compression, which is critical for Know Labs, Inc. (KNW), as its valuation currently depends exclusively on the success of its own clinical trials for a glucose monitor without the support of external M&A transactions.

Key competitors

Forward P/S Multiple DXCM (Dexcom)|Penumbra Inc (PEN) - Market Cap to Future Revenue Ratio|Novanta Corp - Forward P/S Multiple|HAE (Haemonetics Company) - Market Cap to Projected Revenue|INSP: Forward P/S Multiple|PRCT - Market Cap to Expected Sales Ratio|CNMD (CONMED) - Forward P/S Multiple|Forward Price-to-Revenue Multiple Pulse Biosciences Inc (PLSE)|Forward P/S Multiple INMD|Forward P/S Multiple Picard Group (PMI)|Price-to-Projected Revenue Ratio Surmodics, Inc. SRDX|senseonics.com - Price-to-Projected Revenue Ratio|NPCE: Forward Price-to-Revenue Multiple|Forward Price to Sales TCMD (Tactile Systems Technology)|SNWV: Forward P/S Multiple|Market Cap to Future Revenue Ratio Outset Medical Corp (OM)|Price-to-Projected Revenue Ratio SmartVest|LNSR - Projected Price to Revenue|Forward Price-to-Revenue Multiple RCEL (AVITA Medical)|Forward P/S Multiple profoundmedical.com (PROF)|Forward P/S Multiple BDMD (Baird Medical)|Market Cap to Expected Sales Ratio EDAP TMS SA (EDAP)|APYX - Price-to-Projected Revenue Ratio|Future Price to Revenue ICCM|pulmonx.com (LUNG) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple TELA Bio|CTSO (CytoSorbents Corp) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Sensus SRTS|Price-to-Projected Revenue Ratio Zynex, Inc. (ZYXI)|electrocore.com - Market Cap to Projected Revenue|Vicarious Surgical - Forward Price-to-Revenue Multiple|Price to Expected Revenue Ratio IINN (Inspira Technologies Oxy B.H.N. Ltd.)|ICU - Price-to-Projected Revenue Ratio|IRIX - Forward P/S Multiple|ibs.inc (INBS) - Price-to-Projected Revenue Ratio|Market Cap to Projected Revenue XAIR|Price-to-Projected Revenue Ratio Profusa|Market Cap to Future Revenue Ratio STRATA Skin SSKN|Forward Price-to-Revenue Multiple GCTK (GlucoTrack)|Forward Price-to-Revenue Multiple NanoVibronix Inc. NAOV|Venus Concept Inc. - Forward Price-to-Revenue Multiple|Forward Price to Sales NUWE|AEMD - Price-to-Projected Revenue Ratio|ASXC: Price-to-Projected Revenue Ratio|AVGR: Forward P/S Multiple|Biosig Technologies (BSGM) - Forward P/S Multiple|CUTR (Cutera, Inc.) - Forward P/S Multiple|Price-to-Projected Revenue Ratio NARI|Price-to-Projected Revenue Ratio Nevro (NVRO)|Market Cap to Expected Sales Ratio reshapelifesciences.com|Silk Road Medical Inc. - Forward Price-to-Revenue Multiple